Freenome Holdings, Inc.
Other Technology · South San Francisco, California
Freenome Holdings, Inc. is a other technology company based in South San Francisco, California, incorporated in 2016. It has reported $750.6 million raised across 6 Form D filings with the SEC, most recently in 2021.
Freenome is a private biotech company focused on developing blood tests to detect cancer early and make screening accessible for everyone.
| Date | Round | Amount | Raised to date | Lead investor | Source |
|---|---|---|---|---|---|
| 2021-12-07 | — | $243.0M | $750.6M | SEC Form D | |
| 2020-08-26 | — | $270.0M | $507.6M | SEC Form D | |
| 2019-07-24 | — | $160.0M | $237.6M | SEC Form D | |
| 2017-06-07 | —+1 amd | $72.0M | $77.6M | SEC Form D | |
| 2016-06-07 | — | $5.6M | $5.6M | SEC Form D |
SEC rows are Form D filings, where the amount is what was actually sold and amendments update a round rather than adding one. Press rows are split between company-issued releases or wires and editorial or third-party coverage. The total is therefore a floor: a round nobody reported is a round we cannot see. A buyout or control change appears in the timeline but is never added to the total: that money goes to shareholders, not into the company.
Firms whose own published portfolio pages list this company.
Form D is the notice a company files with the SEC when it sells securities without registering them. It reports the amount sold, not a valuation. Figures here are what the filing says. Where a filing is silent, the field is left blank rather than estimated. “Total raised” adds press-reported rounds that never appear in a filing, so it is a floor rather than an audited sum: press amounts are the figures the company announced, and a round nobody reported is a round we cannot see.